Skip to NavigationSkip to content

Bayer’s chief executive to step down in 2016

Published on 04/06/14 at 11:52am
Marijn Dekkers, Bayer chief executive
Marijn Dekkers, Bayer chief executive

Marijn Dekkers the chief executive of German pharma firm Bayer has set his departure date to the end of 2016.

Dekkers who has been at the Bayer helm since the beginning of 2010, is said to have cited family reasons as the motivation for departing the company. 

Bayer says in a statement: “In line with his own wishes, the contract of Dr Marijn Dekkers will be extended by just two years on expiration of the initial five-year period.” 

Werner Wenning, Bayer’s chairman of the supervisory board adds: “We are pleased that Dr Dekkers, under whose leadership Bayer has continued its very positive development, will remain with us for a further two years.”

Bayer now has over two years to decide who will succeed Dekkers, but for the time being the firm has confirmed that Werner Baumann will take on the role of chief strategy and portfolio officer, to “ensure continuity in key aspects of Bayer’s future development.” 

Replacing Baumann as chief financial officer will be Johannes Dietsch, who is based in Shanghai and will assume Bayer’s CFO role there in China. 

Brett Wells 


Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches